New study tracks Long-Term survival in HTLV-1 patients
NCT ID NCT05237245
First seen Nov 20, 2025 · Last updated Jun 14, 2026 · Updated 35 times
Summary
This study follows 69 adults infected with HTLV-1, including those who have developed a rare blood cancer (ATL) and those who have not. Researchers track survival rates over 2 and 5 years and analyze viral and genetic factors. The goal is to better understand how the virus affects health over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HTLV-1 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker Enfants Malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.